C

Capgemini

Global consulting, technology services, outsourcing

Senior Manager - Life Sciences Commercial Strategy & Experience Design

Full-TimeUpdated on 10/21/2026
$140k - $200k+ Variable incentives + Bonuses + Commissions
Expert
Bachelor's
San Francisco, CA, USA+4 moreMore locations: Dallas, TX, USA | Chicago, IL, USA | New York, NY, USA | Atlanta, GA, USA
HybridTravel approximately 30% based on client and engagement needs.
ConsultingStrategy & Management Consulting
No H1B Sponsorship

About the job

Requirements
  • Strong artificial intelligence and generative artificial intelligence literacy, with experience collaborating across strategy, technology, data, and design to deliver responsible artificial intelligence solutions.
  • Deep knowledge of the Life Sciences commercial lifecycle, including launch, pricing, access, distribution, adoption, customer engagement, and channel strategy.
  • Human-centered design expertise across research, journey mapping, service blueprinting, concept development, experience strategy, and product delivery.
  • Ten or more years of experience delivering consulting engagements in Life Sciences commercial strategy, experience strategy, product strategy, service design, or human-centered design, including significant responsibility for leading client engagements and multidisciplinary teams.
  • At least eight years of hands-on Life Sciences commercial experience across areas such as end-to-end drug or therapy launch, segmentation and targeting, sales force sizing and deployment, go-to-market execution, patient services, customer engagement, and commercial operations.
  • Substantive experience in market access, payer strategy, drug pricing, pharmacy and distribution strategy, with an understanding of how these areas influence patient access, provider adoption, and commercial performance.
  • At least eight years of experience leading design-led processes and working alongside digital product and delivery teams, including design research, journey mapping, service blueprinting, concept development, roadmap creation, user stories, agile delivery, and the translation of experience strategy into build priorities.
  • Experience establishing artificial-intelligence-enabled workflows and driving artificial intelligence adoption across teams or clients.
  • Strong executive communication, client relationship, engagement management, and business development capabilities.
  • A bachelor’s degree or equivalent experience.
  • Legal authorization to work in the United States without current or future employer sponsorship.
  • Ability to travel approximately 30% based on client and engagement needs.
Responsibilities
  • Lead end-to-end Life Sciences commercial strategy engagements spanning asset and launch planning, segmentation and targeting, go-to-market strategy, sales force and channel strategy, market access, pricing, patient services, pharmacy and distribution, and loss-of-exclusivity planning.
  • Conduct and oversee human-centered qualitative and quantitative research to identify unmet patient, provider, and customer needs, translating clinical and commercial insights into differentiated journeys, experiences, products, and services.
  • Apply design research, journey mapping, service blueprinting, concept development, and experience strategy to create solutions that connect human needs with commercial objectives and measurable health and business outcomes.
  • Partner with senior client stakeholders and multidisciplinary teams across strategy, design, product, engineering, data, and technology to take work from strategic direction and concept development through roadmaps, agile delivery, launch, adoption, and iteration.
  • Lead engagement delivery and contribute to practice growth by managing scope, timelines, risks, dependencies, margin, and financial performance, while supporting proposals, solution shaping, thought leadership, account development, and team coaching.
Desired Qualifications
  • Experience presenting strategic recommendations to C-suite executives and working directly with senior Life Sciences commercial leaders.
  • Experience leading engagements spanning Life Sciences commercial strategy, experience design, product, data, and technology disciplines.
  • Experience using data, analytics, generative artificial intelligence, or other artificial-intelligence-enabled tools in consulting delivery, including developing an artificial-intelligence-enabled prototype or product.
  • Experience translating experience strategy into product roadmaps and delivery plans alongside engineering and technology teams.
  • Demonstrated contributions to proposals, solution shaping, account development, thought leadership, practice growth, and the development of consulting teams.

About the company

Capgemini helps organizations in consulting, technology services, and outsourcing to drive digital transformation. Its offerings include strategy and transformation consulting; system integration, application development, and IT infrastructure management; and managed IT operations and business processes. It competes through a global footprint in over 50 countries with a local touch, applying AI, cloud, and cybersecurity to real-world problems. Its goal is to help clients achieve strategic objectives and improve efficiency through technology.

Company Size

10,001+

Company Stage

IPO

Headquarters

Paris, France

Founded

1967

Get referred to Capgemini

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • H1 2026 revenue reached €12.082 billion, up 8.8%, and guidance rose to 8.5%-9.0%.
  • HMRC’s June 2026 contract adds multi-year public-sector revenue and validates Capgemini’s sovereign-cloud pitch.
  • Generative and agentic AI exceeded 10% of Q4 2025 bookings, signaling durable demand momentum.

What critics are saying

  • Fit-for-Growth triggered about €700 million restructuring costs across 2026-2027, mostly in 2026.
  • June 30, 2026 filings cite recurring India transfer-pricing tax reassessments and active litigation.
  • AI services commoditize legacy consulting; WNS integration and workforce cuts threaten margin expansion by 2027.

What makes Capgemini unique

  • Capgemini’s October 2025 WNS acquisition created scaled Intelligent Operations and agentic AI delivery.
  • The June 2026 HMRC deal extends a 2004 relationship and embeds Capgemini in UK tax systems.
  • Capgemini’s September 2026 OpenAI Deployment Company investment deepens enterprise AI implementation access.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Paid Vacation
  • Flexible Work Hours
  • Remote Work Options
  • Professional Development Budget
  • Meal Benefits
  • Dental Insurance
  • Life Insurance
  • Performance Bonus
  • Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

5%

2 year growth

5%
InfraSale
Sep 25th, 2026
Capgemini Expands Seattle Presence with Acquisition of Collinear Group

Capgemini has acquired Collinear Group, enhancing its consulting capabilities in the Seattle area. This move signifies a strategic expansion into the growing data center and technology consulting market, which is crucial for InfraSale's audience focused on infrastructure development. Observers should watch for how this acquisition impacts local data center projects and consulting services.

Associated Press
Sep 10th, 2026
42% of consumers confused by life insurance policies, 1 in 4 abandon purchase

Life insurers face a relevance crisis, according to the World Life Insurance Report 2027 from Capgemini and LIMRA. The study surveyed over 6,100 consumers globally and found that whilst 47% consider buying life insurance, more than 40% feel confused or unconvinced by available information. One in four abandon the purchase process. Younger consumers aged 18-40 are particularly affected, with 28% dropping out before completion. Technical language, affordability concerns, and perceived irrelevance drive these exits. The report reveals nearly 40% of policyholders rarely hear from insurers post-purchase, and half who discontinue do so within three years. However, best-in-class insurers—representing just 10% of carriers—achieved 41% higher revenue growth and 12% lower lapse rates through personalised engagement and data-driven strategies.

The Register
Aug 20th, 2026
HMRC awards Capgemini $47M SAP migration contract, extending 28-year relationship

The UK's HM Revenue & Customs has awarded Capgemini a £37 million contract to migrate its Enterprise Tax Management Platform from SAP ECC 6.0 to S/4HANA. The contract runs until 2032, potentially extending Capgemini's involvement with HMRC's tax systems to 28 years since the relationship began in 2004. The platform handles more than £800 billion in tax revenue and payments annually for 40,000 users. HMRC insisted the procurement was fair and competitive, with several bidders competing from the Digital Legacy Application Services framework. Capgemini became HMRC's lead technology supplier in 2004 under the Aspire contract. A 2014 parliamentary committee found that Aspire cost £7.9 billion between 2004 and 2014, generating £1.2 billion in combined profit for Capgemini and Fujitsu.

Yahoo Finance
Jul 30th, 2026
Capgemini H1 net profit drops 31% to $538M despite 8.8% revenue rise and raised FY outlook

French technology company Capgemini reported a 31% drop in net profit to €498 million in the first half of the year, down from €724 million in the same period last year, due to higher expenses. Normalised earnings per share fell 12% to €5.29. Revenue climbed 8.8% to €12.08 billion from €11.11 billion. The company's operating margin rose 9.3% to €1.51 billion. Net other operating income and expenses increased to €628 million from €401 million in the prior-year period. Capgemini raised its fiscal 2026 revenue growth outlook to around 8.5% to 9.0% at constant exchange rates, up from its earlier forecast of 6.5% to 8.5%.

Yahoo Finance
Jul 30th, 2026
Capgemini raises 2026 revenue growth target to 8.5-9% after strong H1 performance

Capgemini has upgraded its 2026 revenue growth outlook following strong first-half performance. The French IT services firm now expects constant currency revenue growth of around 8.5% to 9.0%, up from its previous target of 6.5% to 8.5%. The company reported revenues of €12.1 billion in the first half of 2026, up 8.8% year-on-year, with constant currency growth of 11.3%. Operating margin reached 12.5% of revenues, up 10 basis points year-on-year. Chief executive Aiman Ezzat attributed the performance to strong demand for AI-driven transformation services, particularly agentic AI and physical AI solutions. The company's newly integrated Intelligent Business Operations business line, following the WNS acquisition, is generating significant commercial traction. Capgemini maintained its operating margin target of 13.6% to 13.8% and organic free cash flow guidance of €1.8 billion to €1.9 billion for the full year.